All companies
N

Nalu Bio

Discovers compounds targeting the endocannabinoid system for chronic inflammation and metabolic disorders.

Stage
Series A
Last round
Series A, Feb 2023
Employees
14
Founded
2019
Category
Biotech & life sciences

Scores

Low search fit. Buyers of this kind of product rarely start with a search, so SEO matters less here.

Est. organic visits a month
29
Keywords ranking on Google
15
  • Strength35 / 100

    What the site earns from search today: estimated traffic, ranking keywords, content pages and technical basics.

  • Opportunity2 / 100

    Search demand the site is not capturing yet. It is high when demand is real, strength is low and the keywords are within reach.

  • Demand3 / 100

    How much people search for what this company sells, and how much traffic the top sites in its category earn.

  • Ease65 / 100

    How winnable the buyer keywords are.

  • Technical84 / 100

    Starts at 100 and drops for each problem found on the homepage, robots.txt and sitemap.

Get the report for Nalu Bio

The searches your customers make and the pages to build for them, written by OpenSEO from real SEO data.

Compared with peers

Nalu Bio is above the category median and below the top 10%. The category is Biotech & life sciences, with 118 San Francisco startups on this list.

Estimated organic visits a month. Bars use a log scale.

Buyer keywords to target Suggestions

Searches a buyer of this product might type. They are generated from the company description, not taken from its analytics.

KeywordMonthly searchesDifficulty
therapeutic cannabinoid research10–
endocannabinoid drug discoveryToo low to measure–
endocannabinoid system compoundsToo low to measure–
chronic inflammation drug researchToo low to measure–
target endocannabinoid receptorsToo low to measure–
discover non addictive compoundsToo low to measure–

Monthly searches are US Google averages. Difficulty runs from 0 (easy to rank) to 100 (very hard).

What the site has today

Pages in sitemap
52
Built with
Wix
llms.txt
Yes
Title
Nalu Bio | Unlocking the endocannabinoid system (ECS) for healthier living
Meta description
Our proprietary ECS Technology Platform uses AI and biological modeling to accelerate the development of prescription therapeutics. We’re addressing today’s biological mismatch: chronic inflammation, metabolic dysfunction, and immune dysregulation driven by stress, sedentary lifestyles, and processed diets with a pipeline of ECS therapeutics.
H1
Not found

Page types in the sitemap

Not found: docs, comparison pages, integration pages, customer stories, use case pages, glossary pages, templates, changelog, product pages.

Fixes2

Fix all of them in one go

Copy one prompt with every fix and paste it into Claude Code, Codex or Cursor in your website’s repo. It also tells the agent how to connect OpenSEO for keyword research and a full audit.

  1. Warning

    No H1 heading

    The H1 tells search engines what the page is about.

    <h1>Discovers compounds targeting the endocannabinoid system for chronic inflammation and metabolic disorders</h1>
  2. Nice to have

    Title is 74 characters

    Google cuts titles off at roughly 60 characters.

    Shorten the title to under 60 characters with the main keyword first.

Share this page

Audit every page with OpenSEO

This page covers the homepage, robots.txt and sitemap. OpenSEO also tracks your rankings and shows where competitors get their traffic.

Site checked Nov 18, 2026. Traffic is a modeled estimate and company data can be wrong. Ask for a correction or removal · Methodology